NTLA - Intellia Long-Term Debt Volume

Brandmark of Intellia (NTLA)

The NTLA share price, reflected in the Pakistan chart, is 0.05. The business's success is based on the results of medical tests, not market cycles. Redundant supplies of biomaterials ensure stable development. The company's fundamental growth is based on partnerships with global giants, who are jointly implementing genome editing methods to combat dangerous pathologies.

Intellia Corp (NTLA) - Company Long-Term Liabilities from 07/04/2022 to 10/31/2026

Summary analytical data breakdowns for Intellia (NTLA)

- market price and analyst price targets:
Stock Price intelliatx.com|NTLA - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Intellia Therapeutics|NTLA - Total Company Value
- balance sheet equity data:
Equity per Share Intellia Therapeutics|NTLA - Company Net Assets|Market Cap to Book Value Multiple intelliatx.com|NTLA - Company Total Assets
- debt level and financial liquidity data:
Debt to Capital Intellia Therapeutics|NTLA - Long-Term Debt to Equity|Short-Term Debt to Equity Intellia Corp|NTLA - Company Debts|Debt to Book Capitalization Ratio Intellia Therapeutics|NTLA - Company Long-Term Debts|Short-Term Debt Volume Intellia Therapeutics|Quick Ratio intelliatx.com
- earnings and valuation multiples indicators:
NTLA - Net Income
Analysis of all company metrics:intelliatx.com (NTLA)
Manufactured product of Intellia Corp

Intellia Therapeutics (NTLA) focuses on modernizing production capacities and developing CRISPR laboratories, which requires significant long-term financing. The trend in the company's long-term debt volume reflects the aggregate of liabilities with maturities exceeding one year, where trend stability confirms the resilience of the strategy, while sharp deviations signal liquidity risks or preparations for large-scale infrastructure investments.

Who Intellia Therapeutics competes with

Company Long-Term Debts Tempus Labs TEM|Qiagen - Company Long-Term Debts|Long-Term Debt Volume Ionis Pharmaceuticals, Inc. IONS|Repligen Corp. (RGEN) - Company Long-Term Debt|Company Long-Term Indebtedness RNA|Company Long-Term Liabilities CRSP|WGS (genedx.com) - Amount of Long-Term Liabilities|Company Long-Term Debts RARE|BEAM - Long-Term Debt|Company Long-Term Debt Sarepta Therapeutics Inc SRPT|Twist Bioscience Corp - Company Long-Term Debt|TXG - Company Long-Term Debt|STOK: Company Long-Term Debt|BLFS: Company Long-Term Debts|WVE - Long-Term Debt Volume|MAZE (Maze Tx) - Company Long-Term Debts|Company Long-Term Debts Sionna Corp|Company Long-Term Liabilities PRME (Prime Medicine, Inc.)|TSHA (tayshagtx.com) - Company Long-Term Loans and Borrowings|uniQure - Company Long-Term Liabilities|Amount of Long-Term Liabilities MGTX (MeiraGTx Holdings)|Regenxbio - Company Long-Term Debts|Company Long-Term Loans and Borrowings SLDB (Solid Corp)|OCGN: Company Long-Term Debts|Long-Term Debt pacb.com (PACB)|Company Long-Term Debt Benitec Biopharma|DSGN: Company Long-Term Loans and Borrowings|Company Long-Term Debts RCKT|Company Long-Term Debts 4D Molecular Corp (FDMT)|Company Long-Term Debt Lexeo Therapeutics, Inc. LXEO|KRRO (Korro Bio Inc.) - Long-Term Liabilities|Editas Medicine - Company Long-Term Debts|Long-Term Debt Silence Therapeutics PLC|PRQR (proqr.com) - Company Long-Term Liabilities|Codexis (CDXS) - Company Long-Term Debts|Company Long-Term Liabilities SGMO|NAUT (Nautilus Biotechnology Inc) - Amount of Long-Term Liabilities|Company Long-Term Debts MGX|Long-Term Debt Volume Precision BioSciences Inc.|Company Long-Term Debts GBIO (Generation Bio)|BOLD - Company Long-Term Liabilities|XCUR - Company Long-Term Debt|Long-Term Debt Volume Imunon, Inc. IMNN|phiopharma.com (PHIO) - Company Long-Term Debt|Company Long-Term Indebtedness MBIO|Company Long-Term Liabilities RNAZ|BNGO (Bionano) - Amount of Long-Term Liabilities|Company Long-Term Debt Applied DNA Sciences (APDN)|Company Long-Term Debt BLUE (bluebirdbio.com)|Company Long-Term Debts IPA (ImmunoPrecise Antibodies Ltd.)|Company Long-Term Debts Omega Therapeutics Inc OMGA|Singular Genomics Systems Inc - Company Long-Term Debts|RGLS (Regulus) - Company Long-Term Indebtedness|Syros Pharmaceuticals (SYRS) - Company Long-Term Debt|Company Long-Term Indebtedness TBIO|TCON (TRACON Pharmaceuticals, Inc.) - Company Long-Term Debts|Company Long-Term Debts Unity Biotechnology Inc.